First Quarter Venture Capital Results Slip from Prior Highs, According to Healthcare Corporate Finance News
NORWALK, Conn. (Business Wire EON) April 14, 2008 --
Health Care Venture Capital Investments, First Quarter
Ended March 31, 2008
----------------------------------------------------------------------
Dollar Amount
Sector Number of Deals (in millions)
==========================-=====================-=====================
Medical Devices 32 $663.20
----------------------------------------------------------------------
Pharmaceuticals 16 $400.32
----------------------------------------------------------------------
Biotechnology 24 $360.54
----------------------------------------------------------------------
Biopharmaceuticals 16 $358.85
----------------------------------------------------------------------
Health Care Services 7 $81.60
----------------------------------------------------------------------
e-Health 8 $52.90
----------------------------------------------------------------------
Total 103 $1,917.41
----------------------------------------------------------------------
Nearly 40% of the deals announced had investment sizes of $20 million or more. The average deal size for Q1:08 was $18.6 million, and the median, $15.0 million. The largest deals announced in Q1:08 were all in the health care technology sectors. Included among the largest capital commitments are some tranched financings and some venture investments tied to other financing instruments.
"Many investors are showing a preference for companies with existing products, advanced product candidates or plans to acquire or in-license assets, while others continue to support early-stage enterprises," remarked Gretchen S. Swanson, Editor of Healthcare Corporate Finance News. "Furthermore, right now there are more enticing exit opportunities through M&A than an IPO."
Each of the three largest deals is in the $60 million dollar range, with one announced in each month of the quarter. In January, American Capital invested $66 million in Avalon Laboratories, a supplier of disposable cardiopulmonary vascular cannulae. Taligen Therapeutics announced a $65 million, six-tranche round in February to help move its lead candidates into clinical development. In March, TriVascular2 was formed with $65 million to acquire a subsidiary of Boston Scientific, as well as certain intellectual property of its predecessor company, TriVascular, Inc.
"With liquidity opportunities lacking in the public equity markets, venture capitalists are likely preparing to make additional investments in many of their portfolio companies," commented Stephen M. Monroe, Managing Editor. "However, in some cases, it may be necessary to implement restructuring plans and cutbacks to keep private, development-stage companies afloat in the currently unstable financial markets."
With 32 venture investments totaling $663 million in funding, the medical device sector was the most active in health care during the first quarter, with the greatest amount of funding (35%) and the most deals announced (31%). Nearly 21% of the total dollars invested in health care during the first quarter was committed to pharmaceuticals, while about 19% each went to the biotechnology and biopharmaceutical sectors.
The most active venture capital firms of the quarter, based on publicly announced transactions, participated in four or more rounds. These firms are listed below.
Top Health Care Venture Capital Investors, Q1:08
-------------------------------------------------------------------
Firm Number of Investments
-------------------------------------------------------------------
InterWest Partners 6
-------------------------------------------------------------------
Kleiner Perkins Caufield & Byers 6
-------------------------------------------------------------------
New Enterprise Associates 6
-------------------------------------------------------------------
Polaris Venture Partners 6
-------------------------------------------------------------------
Domain Associates 5
-------------------------------------------------------------------
Versant Ventures 5
-------------------------------------------------------------------
Fidelity Biosciences 4
-------------------------------------------------------------------
MPM Capital 4
-------------------------------------------------------------------
Sofinnova Ventures 4
-------------------------------------------------------------------
Strategic investors that participated in deals during the quarter include Medtronic, MedImmune Ventures, Safeguard Scientifics, Kaiser Permanente Ventures, Mitsubishi Corporation, Novartis Venture Fund and Merck Capital Ventures.
Healthcare Corporate Finance News (http://www.hcfnews.com) reports weekly on financial events in the fast-paced venture capital, private and public equity, and merger and acquisition markets for health care companies, and provides subscribers with access to a searchable online database of health care venture capital deals. This monthly newsletter and weekly email update is published by Irving Levin Associates, Inc., a leading financial publisher and source of market intelligence since 1948. For more information, please call 1-800-248-1668.
* To receive this press release via email, send a message to pressreleases@levinassociates.com.
Do you want to start a new business? There are many different things that you need to consider with business startup. Planning ahead will help you become very successful in your new business. Helping people start new businesses is something that we are very passionate about. It's the American Dream. Many ventures , internet ventures or otherwise, are faced with the challenging task of raising venture capital. The first part of this process is finding the right venture capital firm (VC). While this may seem simple, it isn't. There are thousands of venture capital firms in the United States alone, and going after the wrong ones is one of the most common reasons why companies fail to raise the capital they need. Find all the information and help you need to find internet venture capital (VC)
Related Articles:
Kubera Venture Capital Group Secures Financing from Banco Nacional
Kubera Venture Capital Group, LLC, a privately held real estate investment and development firm, today announced it has obtained a round of financing for its gated residential community, Jade Azul, in Nosara, Costa Rica. Affirming the continued strength of investments in Costa Rica real estate, and the value of the Jade Azul project in particular, the financing was issued by Costa Rica's largest bank, Banco Nacional and will be used to fund further development of the community's infrastructure and community amenities.
Sabal Medical Receives Second Tranche of Venture Capital
Sabal Medical Inc, a privately held company whose products are helping hospitals deliver medications to their patients more safely and efficiently, is pleased to announce that it has closed on the second tranche of its previously announced institutional investment financing (see press release dated February 19, 2008), led by Nexus Medical Partners of Quincy, MA, and its German affiliate, Medicis Nexus Partners GmbH of Munich.
Parature Secures $16 Million in Venture Capital
Fastest growing customer service SaaS company acquires Series B financing from firms with impressive track records of success in the information technology industry .
Venture Capital 101
I. WHAT IS VENTURE CAPITAL?
Swedish High Tech CEOs Invade Washington, DC on the Hunt for Venture Capital
On 13-14 March, Invest in Sweden Agency (ISA) invites high tech corporate and venture capital investors to meet 20 information technology, life science and materials start-ups looking for funding.
TVP, LP Announces Closing of Venture Capital Fund to Address Diabetes, Nutrition and Obesity Utilizing the Pennington Biomedical Research Center
The fund manager of Louisiana Ventures, LP, a $25 million venture capital fund organized two years ago, is pleased to announce it has secured the financial commitments necessary to form a venture capital fund that will commercialize technologies from the Pennington Biomedical Research Center.
Finding a Venture Capital Firm
Many ventures are faced with the challenging task of raising venture capital. The first part of this process is finding the right venture capital firm (VC).
Kubera Venture Capital Group Announces Master Plan for Jade Azul Gated Community in Nosara, Costa Rica
Kubera Venture Capital Group, LLC, a privately held real estate investment and development firm, today announced the release of the Master Plan for its 110-unit gated residential community, Jade Azul, in Nosara, Costa Rica. Offering residents an ecologically-rich lifestyle, the Balinese-inspired community will have a mix of single-family villas, ocean-view condominiums, and commercial amenities. To celebrate this first milestone of 2007, Kubera is offering a unique, limited-time promotion to Jade Azul buyers.
Venture Capital Funding Allows AideRSS to Capitalize on Rapid Internet RSS Growth
PostRank? Process Helps Solve RSS Information Overload Problem Endured by Millions
Identifying the Right Venture Capital Firm Partner
Venture capital firms are comprised of individual partners. These partners make investment decisions and typically take a seat on each portfolio company's Board.
Flypaper Studio, Inc. Closes $3.5 Million in Venture Capital Funding : Company Will Use Funding to Expand Product Offering and Accelerate Marketing
Flypaper Studio, Inc., an innovator of rich media content creation software, today announces the company has closed $3.5 million in funding. The venture capital round comes from Sierra Ventures of Menlo Park, California, and SCF Arizona of Phoenix, Arizona. Both companies contributed to Flypaper Studios? first round of funding, completed in February 2008, in the total amount of $3 million.